報價延遲最少15分鐘:2026/03/02 12:21 EST
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.51 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.13/-0.15
|
|
企業價值
108.42M
|
| 資產負債 |
|
每股賬面淨值
0.02
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Turn Therapeutics Inc is a clinical-stage biotechnology company focused on developing pharmaceutical and medical device products for dermatology, wound care, and infectious disease. The company's proprietary platform technology, called PermaFusion, enhances drug performance by improving the stability and bioavailability of active pharmaceutical ingredients, which allows for reduced doses and fewer side effects. Its primary development programs target skin conditions such as moderate to severe eczema and onychomycosis. |
